[CAS NO. 1254977-87-1]  JNJ-42153605

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1254977-87-1]

Catalog
HY-18162
Brand
MCE
CAS
1254977-87-1

DESCRIPTION [1254977-87-1]

Overview

MDLMFCD22199231
Molecular Weight400.44
Molecular FormulaC22H23F3N4
SMILESFC(C1=C(N2CCC(C3=CC=CC=C3)CC2)C=CN4C1=NN=C4CC5CC5)(F)F

For research use only. We do not sell to patients.

Summary

JNJ-42153605 is a positive allosteric modulator of the metabotropic glutamate 2 ( mGlu2 ) receptor with an EC 50 of 17 nM.


IC50 & Target

mGluR2

17 nM (EC 50 )


In Vitro

JNJ-42153605 is assessed for its selectivity for the mGlu2 receptor and is found to not have agonist or antagonist activity toward other mGlu receptor subtypes up to 30 μM. JNJ-42153605 shows high permeability with no indication for P-glycoprotein efflux [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


In Vivo

JNJ-42153605 shows a central in vivo efficacy by inhibition of REM sleep state at a dose of 3 mg/kg po in the rat sleep-wake EEG paradigm, a phenomenon shown to be mGlu2 mediated. In mice, JNJ-42153605 shows reversed PCP-induced hyperlocomotion with an ED 50 of 5.4 mg/kg sc, indicative of antipsychotic activity. JNJ-42153605 shows a rapid rate of absorption from the gastrointestinal tract, reaching the maximal concentration after 0.5 h. Clearance in vivo is moderate to high in both rat and dog (35 and 29 mL/min/kg, respectively). Elimination halflives are on the shorter side across the species, being 2.7 h in rat and 0.8-1.1 h in dog [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month

Solvent & Solubility

In Vitro:

DMSO : 16.67 mg/mL ( 41.63 mM ; Need ultrasonic)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.4973 mL 12.4863 mL 24.9725 mL
5 mM 0.4995 mL 2.4973 mL 4.9945 mL
10 mM 0.2497 mL 1.2486 mL 2.4973 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: 1.67 mg/mL (4.17 mM); Suspended solution; Need ultrasonic

  • 2.

    Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)

    Solubility: ≥ 1.67 mg/mL (4.17 mM); Clear solution

  • 3.

    Add each solvent one by one: 10% DMSO >> 90% corn oil

    Solubility: ≥ 1.67 mg/mL (4.17 mM); Clear solution

* All of the co-solvents are available by MCE.